Avidity Biosciences's market cap is currently $3.88B. The company's EPS TTM is $-2.898; its P/E ratio is ―; Avidity Biosciences is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 9.56M	$ 9.22M	$ 9.33M	$ 6.79M	$ 2.32M
Gross Profit	$ 7.46M	$ 7.84M	$ 8.69M	$ -30.82M	$ -12.22M
Operating Income	$ -235.60M	$ -178.91M	$ -118.05M	$ -44.28M	$ -17.33M
EBITDA	$ -233.50M	$ -177.53M	$ -117.41M	$ -43.77M	$ -16.75M
Net Income	$ -212.22M	$ -169.08M	$ -117.37M	$ -43.98M	$ -32.12M
Balance Sheet
Cash & Short-Term Investments	$ 595.35M	$ 610.73M	$ 405.54M	$ 328.14M	$ 94.58M
Total Assets	$ 628.55M	$ 638.80M	$ 427.58M	$ 333.90M	$ 96.91M
Total Debt	$ 9.85M	$ 10.69M	$ 9.96M	$ 938.00K	$ 4.94M
Net Debt	$ -175.23M	$ -329.71M	$ -395.58M	$ -327.20M	$ -89.64M
Total Liabilities	$ 127.79M	$ 60.73M	$ 46.15M	$ 27.68M	$ 162.26M
Stockholders' Equity	$ 500.76M	$ 578.08M	$ 381.43M	$ 306.22M	$ -65.36M
Cash Flow
Free Cash Flow	$ -123.29M	$ -139.09M	$ -98.55M	$ -38.21M	$ 2.25M
Operating Cash Flow	$ -119.06M	$ -136.27M	$ -94.81M	$ -37.12M	$ 2.49M
Investing Cash Flow	$ -130.07M	$ -189.96M	$ -82.52M	$ -7.79M	$ -235.00K
Financing Cash Flow	$ 93.86M	$ 346.17M	$ 176.32M	$ 272.04M	$ 89.23M

Currency in USD

Avidity Biosciences Earnings and Revenue History

Income Statement >

Avidity Biosciences Debt to Assets

Balance Sheet >

Avidity Biosciences Cash Flow

Cash Flow >

Avidity Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing